Bayer Korea Receives Approval for Eylea 8mg for Retinal Diseases
[메디칼업저버 양영구 기자] Bayer Korea announced on the 4th that it has received approval for 8mg of Eylea (ingredient name: aflibercept) from the Ministry of Food and Drug Safety. Eylea is an injection administered into the vitreous body to treat major retinal diseases such as age-related macular degeneration and vision loss due to diabetic macular […]
HLB liver cancer treatment Rivoceranib passes the 9th mark for US approval, Jinyanggon speeds up commercialization
[비즈니스포스트] Jin Yang-gon, Chairman of HLB Group, has reached the final hurdle of achieving results with the liver cancer treatment drug Rivoceranib. Since the US Food and Drug Administration (FDA)’s new drug approval process was completed without any particular problems, all that remains is to wait for approval. Jinyanggon commercialization speed battle” height=”150″ src=” width=”300″ […]
Japan Plans to Export Next-Generation Fighter Jets in Partnership with UK and Italy
Japan plans to allow the export of next-generation fighter jets jointly developed with the UK and Italy to third countries. According to the Yomiuri Shimbun on the 15th, the Liberal Democratic Party of Japan and the ruling Komeito coalition agreed to allow the export of defense equipment limited to next-generation fighter jets at a meeting […]
EC permission to celebrate Book Festival
The Election Commission (EC) has given permission to celebrate the Book Festival by distributing textbooks on January 1. On Sunday (December 24), the deputy secretary of EC’s election management branch said. Atiyar has sent a letter in this regard to the Secretary of the Secondary and Higher Education Department of the Ministry of Education. As […]
‘If you want to do business, you must get permission’
Dhaka South City Corporation (DSCC) Mayor Barrister Sheikh Fazle Noor Tapos said that if you want to do business in the DSCC area, you must take permission (trade license). Also, no one will be allowed to trade. Dhaka South City Corporation Head Office Nagar Bhaban Mayor Hanif Auditorium on Tuesday (November 7) during the overall […]
Ferrari Accepts Cryptocurrency Payments in the US and Plans Expansion to Europe
Ferrari Now Accepting Cryptocurrency Payments in the United States By Kim Hani, Money Today Reporter [Seoul, South Korea – October 14, 2023] Ferrari, the renowned luxury car manufacturer, has announced that it is now accepting cryptocurrency payments in the United States. This move comes in response to increasing customer demand and is part of Ferrari’s […]
GC Green Cross MS Receives Approval for Dengue Virus Rapid Diagnostic Kit from Ministry of Food and Drug Safety
GC Green Cross MS Receives Approval for Dengue Virus Rapid Diagnostic Kit GENEDIA W Dengue NS1 Ag and GENEDIA W Dengue IgM/IgG Ab obtain export approval from Ministry of Food and Drug Safety SEOUL – GC Green Cross MS announced on the 18th that it has received export approval for its new diagnostic kit designed […]
Celltrion Applies for Approval of ‘STELARA’ Biosimilar in Australia
Celltrion Applies for Approval of Autoimmune Disease Treatment Biosimilar in Australia The CEO of Celltrion, Ki Woo-seong, has submitted an application for approval of the biosimilar ‘CT-P43’, an item for the treatment of autoimmune diseases, to the Therapeutic Goods Administration (TGA) of Australia. The application, issued on the 31st, encompasses all indications of the originator […]
Mobilization in Ukraine 2023 – can a man move to another city during the war – do you need permission from the military registration and enlistment office
© Sergey Nuzhnenko / Radio Liberty Due to the full-scale invasion of Russia in Ukraine, a general mobilization continues, during which men of military age receive subpoenas. There are also certain prohibitions and restrictions for those liable for military service. Lawyer and leading legal adviser of Nota Group Anton Marynich explained whether men who want […]
AstraZeneca’s ‘Imfinzi’ Receives First-Line Indication for Hepatocellular Carcinoma Combination Therapy with Imudo
AstraZeneca Korea, headed by CEO Kim Sang-pyo, has announced that its anti-PD-L1 immuno-oncology drug, ‘Imfinzi (Dervalumab),’ has received approval from the Ministry of Food and Drug Safety for an additional indication as a first-line treatment option for advanced or unresectable hepatocellular carcinoma. This approval was granted based on the findings from the phase 3 HIMALAYA […]
